Intracranial Hemorrhages
Bleeding within the SKULL, including hemorrhages in the brain and the three membranes of MENINGES. The escape of blood often leads to the formation of HEMATOMA in the cranial epidural, subdural, and subarachnoid spaces.
Subtype terms (7)
More specific conditions that are subtypes of Intracranial Hemorrhages in the MeSH hierarchy.
- Cerebral Hemorrhage
94 drugs (70 approved, 24 experimental)
- Hematoma, Epidural, Cranial
- Hematoma, Subdural
16 drugs (14 approved, 2 experimental)
- Intracranial Hemorrhage, Hypertensive
12 drugs (11 approved, 1 experimental)
- Intracranial Hemorrhage, Traumatic
2 drugs approved
- Pituitary Apoplexy
- Subarachnoid Hemorrhage
106 drugs (85 approved, 21 experimental)
Drugs by status
Phase 4 trials (14)
Phase 3 trials (14)
Phase 2 trials (4)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (15)
- The Medicines Company
- Cristália Produtos Químicos Farmacêuticos Ltda.
- Cumberland Pharmaceuticals
- Portola Pharmaceuticals
- Otsuka
- University of Roma La Sapienza
- McMaster University
- Methodist Healthcare
- Shanghai University of Traditional Chinese Medicine
- University of Heidelberg
- Columbia University
- University of Ulsan
- Adolphe Rothschild Ophtalmologic Foundation
- Rouen Normandy University
- Government of France
Organization Involved with Phase 3 Indications (25)
- National Center for Research Resources (NCRR)
- Brown University
- Case Western Reserve University
- Emory University
- Indiana University
- NHS Lothian
- Shaanxi Provincial People's Hospital
- Stanford University
- University of Edinburgh
- University of New Mexico
- University of Tennessee
- Wayne State University
- Yale University
- Prince of Songkla University
- University of Cincinnati
- University of Utah
- Thailand Research Fund
- Jiao Tong University
- National Taiwan University
- University of Perugia
- KhonKaen University
- George Washington University
- Xi'an Medical University
- National Institute of Child Health and Human Development (NICHD)
- People's Liberation Army of China
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (13)
- PhytoHealth Corporation
- National Institutes of Health (NIH)
- Duke University
- RTI International
- Tufts University
- University of Iowa
- Pomeranian Medical University
- University of Texas at Houston
- University of Alabama, Birmingham
- Sheila B. Terry Memorial Research Fund
- China Medical University
- Yantai YenePharma Co., Ltd.
- The University of Texas, Dallas
Organization Involved with Other Experimental Indications (3)